s20098 has been researched along with Cognitive Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allaïli, N; Euvrard, M; Fossati, P; Franc, B; Gabriel, C; Lanfumey, L; Lehericy, S; Marday, T; Martin, V; Mocaër, E; Riffaud, A | 1 |
| Becker, A; Braun, H; Eisenacher, S; Englisch, S; Jung, HS; Lewien, A; Meyer-Lindenberg, A; Nowak, U; Thiem, J; Zink, M | 1 |
| Can, ÖD; Demir Özkay, Ü; Üçel, Uİ; Ulupınar, E | 1 |
3 other study(ies) available for s20098 and Cognitive Dysfunction
| Article | Year |
|---|---|
Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice.
Topics: Acetamides; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Depressive Disorder; Disease Models, Animal; Disks Large Homolog 4 Protein; Gene Expression Regulation; Hippocampus; Humans; Memory Disorders; Mice; Microfilament Proteins; Nerve Tissue Proteins; Neuronal Plasticity; Stress, Psychological; Synapsins; Synaptophysin | 2017 |
Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study.
Topics: Acetamides; Adult; Antipsychotic Agents; Cognitive Dysfunction; Depression; Drug Therapy, Combination; Female; Humans; Male; Neuropsychological Tests; Schizophrenia | 2018 |
The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers.
Topics: Acetamides; Animals; Cell Count; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Hippocampus; Male; Maze Learning; Memory; Neurons; Nootropic Agents; Rats, Sprague-Dawley | 2018 |